Reports and Testimonies - Browse by topic

Browse By:
  
All Topics » Health Care » Program evaluation
Sort by Results per page Search within "Program evaluation"

Program evaluation (1 - 10 of 413 items) in Custom Date Range

GAO's 2013 High-Risk Update

Medicare and Medicaid
GAO-13-433T, Feb 27, 2013

Medicare Part D Coverage Gap

Discount Program Effects and Brand-Name Drug Price Trends
GAO-12-914, Sep 28, 2012

Medicare

Implementation of Financial Incentive Programs under Federal Fraud and Abuse Laws
GAO-12-355, Mar 30, 2012

Drug Shortages

FDA's Ability to Respond Should Be Strengthened
GAO-12-116, Nov 21, 2011

Medicaid Program Integrity

Expanded Federal Role Presents Challenges to and Opportunities for Assisting States
GAO-12-288T, Dec 7, 2011

EPA Health Risk Assessments

Oversight and Sustained Management Key to Overcoming Challenges
GAO-12-148T, Oct 6, 2011

DOD and VA Health Care

Action Needed to Strengthen Integration across Care Coordination and Case Management Programs
GAO-12-129T, Oct 6, 2011

Medicare Part D

Instances of Questionable Access to Prescription Drugs
GAO-12-104T, Oct 4, 2011

Medicare Part D

Instances of Questionable Access to Prescription Drugs
GAO-11-699, Sep 6, 2011

Drug Pricing

Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement
GAO-11-836, Sep 23, 2011
123456789Next >